Search alternatives:
significantly altered » significantly affected (Expand Search), significantly elevated (Expand Search), significantly lower (Expand Search)
treatment decreased » treatment increases (Expand Search)
altered decrease » altered release (Expand Search), observed decrease (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
Showing 61 - 80 results of 30,673 for search '(( significantly altered decrease ) OR ( significant ((teer decrease) OR (treatment decreased)) ))', query time: 0.63s Refine Results
  1. 61
    Evaluation of <i>in vitro</i> activity of LNP-siRNA on LX-2 cells stimulated by 2 ng/mL of TGF-β.

    Evaluation of <i>in vitro</i> activity of LNP-siRNA on LX-2 cells stimulated by 2 ng/mL of TGF-β. by Ying-Chou Chen (263436)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  2. 62
    Fig 7 -

    Fig 7 - by Ying-Chou Chen (263436)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 63
    Cellular uptake properties of LNP-siRNA by LX-2 cells.

    Cellular uptake properties of LNP-siRNA by LX-2 cells. by Ying-Chou Chen (263436)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  4. 64
    Serum cytokine concentrations and venous immune cell profiles in naïve and <i>S</i>. <i>mansoni</i>-infected mice at 10 weeks post-infection.

    Serum cytokine concentrations and venous immune cell profiles in naïve and <i>S</i>. <i>mansoni</i>-infected mice at 10 weeks post-infection. by Ying-Chou Chen (263436)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 65
    Proposed mechanism of LNP-siTGFβRI action on schistosomiasis-induced liver fibrosis.

    Proposed mechanism of LNP-siTGFβRI action on schistosomiasis-induced liver fibrosis. by Ying-Chou Chen (263436)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  6. 66
    Effect of intravenous injection of LNP-siTGFβRI on <i>Schistosoma mansoni</i>-induced liver fibrosis in mice.

    Effect of intravenous injection of LNP-siTGFβRI on <i>Schistosoma mansoni</i>-induced liver fibrosis in mice. by Ying-Chou Chen (263436)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  7. 67
    Different inhibitors and their endocytic pathways inhibited.

    Different inhibitors and their endocytic pathways inhibited. by Ying-Chou Chen (263436)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  8. 68
    Raw data of the results in all figures.

    Raw data of the results in all figures. by Ying-Chou Chen (263436)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  9. 69
    Characterization of LNP-siTGFβRI.

    Characterization of LNP-siTGFβRI. by Ying-Chou Chen (263436)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  10. 70
    Physicochemical parameters of LNP-RNAs used in the study.

    Physicochemical parameters of LNP-RNAs used in the study. by Ying-Chou Chen (263436)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  11. 71
    Fomepizole treatment decreases the NAD(H) pool, impairs ATP production, and enhances ribosomal targeting antibiotic efficacy.

    Fomepizole treatment decreases the NAD(H) pool, impairs ATP production, and enhances ribosomal targeting antibiotic efficacy. by Hansol Im (14803255)

    Published 2023
    Save to List
    Saved in:
  12. 72
    Histopathological alteration of liver and kidney tissues.

    Histopathological alteration of liver and kidney tissues. by Prapaporn Chaniad (9761710)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  13. 73
    Change in SOS values over time after collagenase treatment among young, middle-aged, and old groups.

    Change in SOS values over time after collagenase treatment among young, middle-aged, and old groups. by Katsutoshi Miura (9600433)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  14. 74
    TUG1 does not influence migration in combination with VEGFA treatment.

    TUG1 does not influence migration in combination with VEGFA treatment. by Anna Theresa Gimbel (13883632)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  15. 75
    MAF1 protein expression by patient race and age.

    MAF1 protein expression by patient race and age. by Stephanie Cabarcas-Petroski (9631636)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  16. 76
    Analysis of MAF1 as a candidate predictive biomarker in HER2-positive breast cancer.

    Analysis of MAF1 as a candidate predictive biomarker in HER2-positive breast cancer. by Stephanie Cabarcas-Petroski (9631636)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  17. 77
    MAF1 protein expression by stage and tumor histology.

    MAF1 protein expression by stage and tumor histology. by Stephanie Cabarcas-Petroski (9631636)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  18. 78
    MAF1 and TFIIIB are differentially expressed in response to the CDK4/6 inhibitor abemaciclib.

    MAF1 and TFIIIB are differentially expressed in response to the CDK4/6 inhibitor abemaciclib. by Stephanie Cabarcas-Petroski (9631636)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  19. 79
    Top ten neratinib-treated sensitive (upper panel) and resistant (lower panel) CTRP breast cancer cell lines.

    Top ten neratinib-treated sensitive (upper panel) and resistant (lower panel) CTRP breast cancer cell lines. by Stephanie Cabarcas-Petroski (9631636)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  20. 80
    KEGG pathway analysis for MAF1.

    KEGG pathway analysis for MAF1. by Stephanie Cabarcas-Petroski (9631636)

    Published 2023
    Subjects:
    Save to List
    Saved in:

Search Tools: